International Hepatology Archives - Page 11 of 48

2024 Nobel Prize | MicroRNAs (miRNAs) and Liver Diseases

By Mourabit Halima 2024.10.16

On October 7, 2024, the Nobel Prize in Physiology or Medicine was awarded to American scientist Victor Ambros and American biologist Gary Ruvkun. They were recognized for their discovery of…

Dr. Lai Wei: Interpretation of Key Points from the 2024 Edition of the Chinese Guidelines for the Prevention and Treatment of Metabolic (Non-Alcoholic

By Lisa Cui 2024.10.15

Editor's note: Liver diseases, primarily viral hepatitis, metabolic-associated fatty liver disease (MAFLD), and alcoholic liver disease, affect approximately 400 million people in China. With the increasing pace of life, unhealthy…

Impact of Gut Microbiota on Patients with Decompensated Cirrhosis

By Lisa Cui 2024.10.14

Editor’s note: The human gastrointestinal tract hosts trillions of microbes, including bacteria, fungi, and viruses, which play essential roles in physiological functions and disease mechanisms. Extensive research has demonstrated that…

JOH丨Optimizing Algorithms to Narrow the Gray Zone in Diagnosing Clinically Significant Portal Hypertension

By Peter W. PENG 2024.10.12

Editor’s note: Portal hypertension (PHT) in cirrhosis is a leading cause of complications in patients with compensated chronic liver disease (cACLD). Clinically significant portal hypertension (CSPH) is closely linked to…

Dr. Jidong Jia Discusses the Establishment of the World Association of Chinese Doctors Physicians Hepatology Committee

By Lisa Cui 2024.10.11

Editor's Note: Liver diseases pose a serious threat to human health, with complex and varied courses that range from chronic hepatitis, liver fibrosis, and cirrhosis to liver failure and hepatocellular…

2024 CACA丨 How to Balance Hepatic Adjuvant Therapy? Dr. Minshan Chen Shares Advances and Strategies in Liver Cancer Adjuvant Treatment

By Peng Longmei 2024.10.09

Hepatocellular carcinoma (HCC), often called the "king of cancers," not only has a low survival rate in advanced stages but also carries a high risk of postoperative recurrence, with a…

Dr. Feng Wang: Current Status and Challenges of Hepatocellular Carcinoma (HCC) Conversion Therapy in the Era of Integrated Medicine

By Lisa Cui 2024.10.08

Liver cancer is one of the most common malignant tumors in China, ranking second in cancer-related deaths. This highlights the significant burden of liver cancer prevention and treatment in the…

Sino-Foreign Dialogue on the Banks of the Yangtze River: Experts’ High-end Talks to Explore the Frontiers and Cooperation Paths of Viral Hepatitis Res

By Peng Longmei 2024.09.29

Editor's note: The Mid-Autumn Festival, a traditional Chinese festival, has just passed. Many experts and scholars in the field of infectious diseases and liver diseases from home and abroad gathered…

Dr Wai-Kay Seto’s Team: Optimized Glycemic Control Reduces Hepatocellular Carcinoma and Liver-Related Mortality in Patients with Diabetes

By El Bachir MOURABIT 2024.09.29

Editor's Note: Liver cancer ranks as the third leading cause of cancer deaths globally, with a fatality rate as high as 85%. Diabetes mellitus (DM) emerges as a significant risk…

Hepatology丨MELD-Na Score Predicts Long-Term Clinical Outcomes After TIPS Surgery

By Lisa Cui 2024.09.27

Editor's Note: The Advancing Liver Therapeutic Approaches (ALTA) research group is an international organization dedicated to advancing new methods of liver disease treatment. Its members are from leading medical institutions…